-
RISS 활용도 분석
-
일본/중국/유럽자료
-
최신/인기 학술자료
-
해외논문구매대행(E-DDS)
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 송재훈 (검색결과 437 건)
- 무료
- 기관 내 무료
- 유료
-
-
-
-
-
-
-
-
-
투자결정요인과 기업특성요인이 한국기업의 對중국 투자전략 수립에 미치는 영향에 관한 연구
송재훈 대한경영학회 2003 大韓經營學會誌 Vol.16 No.6
A Study on the Effect that Decision-Making Factors and Firm's Characteristic Factors Influences on Investment Strategy Applicable to Korean Firm's FDI in China Song, Jae-Hoon*This article, using the J.H.Dunning's Eclectic Theory(OLI model), identifies the decision-making factors and firm's characteristic factors that explain Korean firms' FDI activities in China from 1988 to 2002. Section "Ⅰ" offers data on Korean firms' FDI activities in China for each year between to 1988 and 2002 and in aggregate for that period : the number of FDI, their dollar value, preferred geographical location, targeted industries, and degree of equity of ownership. Section "Ⅱ", using the J.H.Dunning's model, identifies the characteristics of Korean firms investing in China, their motivation for doing so, and the decision-making factors and firm's characteristic factors guiding their FDI decisions.攀* Associate Professor Division of Distribution & Trade, Woosuk Univresity.攀攀The primary motivations for FDI by Korean firms in China are the availability of lower labor cost and the attraction of a rapidly growing market. This research also found that the FDI pattern is increasingly changing from investment in labor-intencive, low technology industry to high technology, capital-intencive industries. As per this study, decision-making factors of importance are ownership- specific and location-specific advantages. Internalization-incentive advantages are not applicable to Korean firms' investment decisions.
-
송재훈,정기석,강문원,배현주,서지영,심태선,안중현,안철민,우준희,이남용,이동건,이미숙,이상무,이영선,이혁민,정두련,김도진 대한감염학회 2009 Infection and Chemotherapy Vol.41 No.3
A successful therapy of community-acquired pneumonia requires appropriate empirical antimicrobial therapy. Etiology and antimicrobial susceptibility of major pathogens of pneumonia can differ by country. Therefore, an ideal treatment guideline of community-acquired pneumonia should be based on the studies performed in each country. We developed a treatment guideline for community-acquired pneumonia in immunocompetent adults in Korea. This guideline was developed by the joint committee of the Korean Society for Chemotherapy, the Korean Society of Infectious Diseases, and the Korean Academy of Tuberculosis and Respiratory diseases.
